BiotechTube
Home/Incannex Healthcare/Dr. Paul Liknaitzky
DP

Dr. Paul Liknaitzky

Scientific Advisory Board Member - Psychedelic Research Lead

Incannex Healthcare

Therapeutic Areas

Sleep DisordersPsychiatryNeurologyInflammatory Diseases

Incannex Healthcare Pipeline

DrugIndicationPhase
IHL-42XObstructive Sleep ApneaPhase 2/3
Psilocybin-assisted TherapyGeneralized Anxiety DisorderPhase 2b
IHL-675AInflammatory Conditions (Rheumatoid Arthritis/Lung Inflammation)Preclinical
CBD-based formulationTraumatic Brain Injury/ConcussionPreclinical
IHL-216ANeuroprotectionPreclinical

Leadership Team at Incannex Healthcare

JL
Joel Latham
Chief Executive Officer & Managing Director
SB
Stephen Bond
Chief Financial Officer
DM
Dr. Mark Bleackley
Chief Scientific Officer
DJ
Dr. Julian Kenyon
Medical Director (UK)
PW
Peter Wills AC
Non-Executive Chairman
T(
Terence (Terry) O'Brien
Non-Executive Director
PH
Paul Hopper
Non-Executive Director
PL
Professor Leon Lack
Scientific Advisory Board Member - Sleep Psychology
PD
Professor Danny Eckert
Scientific Advisory Board Member - Sleep Physiology and OSA
View full Incannex Healthcare profile